An Open-label, Multi-center, Randomized, Evaluator-Blinded Study to Evaluate the Safety and Efficacy of Two Treatment Regimens Involving Vectical (Calcitriol) Ointment 3 microg/g and Clobex (Clobetasol Propionate) Spray, 0.05% in the Treatment of Moderate Plaque Psoriasis.

Trial Profile

An Open-label, Multi-center, Randomized, Evaluator-Blinded Study to Evaluate the Safety and Efficacy of Two Treatment Regimens Involving Vectical (Calcitriol) Ointment 3 microg/g and Clobex (Clobetasol Propionate) Spray, 0.05% in the Treatment of Moderate Plaque Psoriasis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Oct 2012

At a glance

  • Drugs Calcitriol; Clobetasol
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Galderma
  • Most Recent Events

    • 08 Feb 2011 Results presented at the 69th Annual Meeting of the American Academy of Dermatology.
    • 04 Mar 2010 Actual end date (February 2010) added as reported by ClinicalTrials.gov.
    • 04 Mar 2010 Actual patient number (138) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top